Drug recall · May 22, 2024
MethylPREDNISolone Acetate Injectable Suspension recall
Why: Presence of Particulate Matter: Potential for black particulates in the drug product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose Vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, Made in India. NDC: 25021-820-10
- Lots / codes
Lots 5100186, 5100187, 5100188, 5100189, Exp 01/31/2025
- Quantity
- 14,360 vials
- Company
- Sagent Pharmaceuticals, Schaumburg, IL
- Distribution
- Nationwide in the USA
- Initiated
- April 25, 2024 · Voluntary: Firm initiated
- Classified
- May 15, 2024
- Reported
- May 22, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylprednisolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.